Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Anderer

Showing results (51-60 of 84) with videos related to

Pageof 9
Sort By:
Human Psychopharmacology|January 9, 2008
Double-blind, placebo-controlled, multiple-ascending-dose study on the effects of ABIO-08/01, a novel anxiolytic drug, on perception and cognition, utilizing event-related potential mapping and low-resolution brain electromagnetic tomographyPeter Anderer, Bernd Saletu, Michael Wolzt, et al.
Neuropsychobiology|May 26, 2005
On the pharmacotherapy of sleep bruxism: placebo-controlled polysomnographic and psychometric studies with clonazepamAlexander Saletu, Silvia Parapatics, Bernd Saletu, et al.
Alcohol and Alcoholism (Oxford, Oxfordshire)|April 15, 2004
Differences in brain function between relapsing and abstaining alcohol-dependent patients, evaluated by EEG mappingGerda M Saletu-Zyhlarz, Oliver Arnold, Peter Anderer, et al.
European Archives of Psychiatry and Clinical Neuroscience|November 13, 2004
EEG-mapping differences between narcolepsy patients and controls and subsequent double-blind, placebo-controlled studies with modafinilMichael T Saletu, Peter Anderer, Gerda M Saletu-Zyhlarz, et al.
Psychoneuroendocrinology|February 8, 2003
Effects of hormone replacement therapy on perceptual and cognitive event-related potentials in menopausal insomniaPeter Anderer, Heribert V Semlitsch, Bernd Saletu, et al.
Critical Care Medicine|October 24, 2002
Effect of rest on physicians' performance in an emergency department, objectified by electroencephalographic analyses and psychometric testsRichard Frey, Kathrin Decker, Lutz Reinfried, et al.
Journal of Clinical Sleep Medicine : JCSM : Official Publication of the American Academy of Sleep Medicine|March 4, 2021
Estimating sleep stages using cardiorespiratory signals: validation of a novel algorithm across a wide range of sleep-disordered breathing severityJessie P Bakker, Marco Ross, Ray Vasko, et al.
Maturitas|June 28, 2005
Age-related cognitive decline in the menopause: effects of hormone replacement therapy on cognitive event-related potentialsPeter Anderer, Bernd Saletu, Doris Gruber, et al.
Sleep|July 3, 2022
Scoring sleep with artificial intelligence enables quantification of sleep stage ambiguity: hypnodensity based on multiple expert scorers and auto-scoringJessie P Bakker, Marco Ross, Andreas Cerny, et al.
Neuropsychobiology|April 15, 2009
Double-blind, placebo-controlled, multiple-ascending-dose study on the pharmacodynamics of ABIO-08/01, a new CNS drug with potential anxiolytic activity. 1. EEG mapping, psychometric and tolerability findingsGerda M Saletu-Zyhlarz, Peter Anderer, Michael Wolzt, et al.
Pageof 9

Showing results (51-60 of 84) with videos related to

Sort By:
Pageof 9
Human Psychopharmacology|January 9, 2008
Double-blind, placebo-controlled, multiple-ascending-dose study on the effects of ABIO-08/01, a novel anxiolytic drug, on perception and cognition, utilizing event-related potential mapping and low-resolution brain electromagnetic tomographyPeter Anderer, Bernd Saletu, Michael Wolzt, et al.
Neuropsychobiology|May 26, 2005
On the pharmacotherapy of sleep bruxism: placebo-controlled polysomnographic and psychometric studies with clonazepamAlexander Saletu, Silvia Parapatics, Bernd Saletu, et al.
Alcohol and Alcoholism (Oxford, Oxfordshire)|April 15, 2004
Differences in brain function between relapsing and abstaining alcohol-dependent patients, evaluated by EEG mappingGerda M Saletu-Zyhlarz, Oliver Arnold, Peter Anderer, et al.
European Archives of Psychiatry and Clinical Neuroscience|November 13, 2004
EEG-mapping differences between narcolepsy patients and controls and subsequent double-blind, placebo-controlled studies with modafinilMichael T Saletu, Peter Anderer, Gerda M Saletu-Zyhlarz, et al.
Psychoneuroendocrinology|February 8, 2003
Effects of hormone replacement therapy on perceptual and cognitive event-related potentials in menopausal insomniaPeter Anderer, Heribert V Semlitsch, Bernd Saletu, et al.
Critical Care Medicine|October 24, 2002
Effect of rest on physicians' performance in an emergency department, objectified by electroencephalographic analyses and psychometric testsRichard Frey, Kathrin Decker, Lutz Reinfried, et al.
Journal of Clinical Sleep Medicine : JCSM : Official Publication of the American Academy of Sleep Medicine|March 4, 2021
Estimating sleep stages using cardiorespiratory signals: validation of a novel algorithm across a wide range of sleep-disordered breathing severityJessie P Bakker, Marco Ross, Ray Vasko, et al.
Maturitas|June 28, 2005
Age-related cognitive decline in the menopause: effects of hormone replacement therapy on cognitive event-related potentialsPeter Anderer, Bernd Saletu, Doris Gruber, et al.
Sleep|July 3, 2022
Scoring sleep with artificial intelligence enables quantification of sleep stage ambiguity: hypnodensity based on multiple expert scorers and auto-scoringJessie P Bakker, Marco Ross, Andreas Cerny, et al.
Neuropsychobiology|April 15, 2009
Double-blind, placebo-controlled, multiple-ascending-dose study on the pharmacodynamics of ABIO-08/01, a new CNS drug with potential anxiolytic activity. 1. EEG mapping, psychometric and tolerability findingsGerda M Saletu-Zyhlarz, Peter Anderer, Michael Wolzt, et al.
Pageof 9